InvestSMART

Resonance Health Limited (ASX:RHT)

ALERT: Price-sensitive ASX Announcement for RHT
Current share price for RHT : $0.048 0.009 (23.08%)+
Announcement
Release
16 Mar 2026 2:18PM
Price at Release
$0.039
Full Release
download
Summary
Resonance Health Limited has announced the receipt of a research and development (R&D) tax incentive refund totaling $732,851 from the Australian Taxation Office. This refund is derived from the company's R&D activities for the financial year 2025, offset by income taxes payable based on the company's financial performance in the same year. This financial boost will be reflected in their cash flow statements in the upcoming quarterly report. The announcement has been officially sanctioned by the company's Board of Directors.
Key Points
  • Resonance Health Limited received an R&D tax incentive refund from the Australian Taxation Office amounting to $732,851.
  • The refund represents the net difference between the R&D tax incentive for FY2025, which was $832,959, and income taxation payable of $100,108.
  • This refund will be included in the company's cash position in the March 2026 Appendix 4C & Quarterly Activities Report.
  • The announcement was authorized by the Board of Directors of Resonance Health Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.